Conference: Innovative Approaches to Clinical Biomarker Validation- 10/25/2018

Biomarkers have potential to transform drug development and clinical practice. However, the number of validated biomarkers, whose properties and utility are well-understood, remains relatively few. New scientific and regulatory approaches are thus needed to generate or capture the data necessary to validate biomarkers and ensure their safe and reliable use.

The speaker lineup for this one-day event includes leadership from both public and private organizations who are at the cutting edge of clinical data science. Come hear about these exciting initiatives, how they may be able to deliver on the promise of biomarkers, and then engage with us in a discussion of the ethical challenges and opportunities.